학술논문

Comparison of the Profile of the AML Drug Midostaurin (Rydapt (R)) As a Kinase Inhibitor with Those of Its Predominant Primary Human Metabolites
Document Type
Journal
Source
BLOOD; DEC 7 2017, 130 3p. Supplement: 1
Subject
Language
English
ISSN
15280020